Phenotypic spectrum associated with SPECC1L pathogenic variants: new families and critical review of the nosology of Teebi, Opitz GBBB, and Baraitser-Winter syndromes.
Abnormalities, Multiple
/ genetics
Adolescent
Adult
Child
Child, Preschool
Craniofacial Abnormalities
/ genetics
Esophagus
/ abnormalities
Facies
Female
Foot Deformities, Congenital
/ genetics
Growth Disorders
/ genetics
Hand Deformities, Congenital
/ genetics
Humans
Hydrocephalus
/ genetics
Hypertelorism
/ genetics
Hypospadias
/ genetics
Male
Mental Retardation, X-Linked
/ genetics
Mutation
Obesity
/ genetics
Pedigree
Phenotype
Phosphoproteins
/ genetics
Bicornuate uterus
MID1
Nosology
Omphalocele
Opitz BBBG syndrome
SPECC1L
Teebi hypertelorism syndrome
Journal
European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
24
06
2018
revised:
25
09
2018
accepted:
22
11
2018
pubmed:
26
11
2018
medline:
13
3
2020
entrez:
26
11
2018
Statut:
ppublish
Résumé
The SPECC1L protein plays a role in adherens junctions involved in cell adhesion, actin cytoskeleton organization, microtubule stabilization, spindle organization and cytokinesis. It modulates PI3K-AKT signaling and controls cranial neural crest cell delamination during facial morphogenesis. SPECC1L causative variants were first identified in individuals with oblique facial clefts. Recently, causative variants in SPECC1L were reported in a pedigree reported in 1988 as atypical Opitz GBBB syndrome. Six families with SPECC1L variants have been reported thus far. We report here eight further pedigrees with SPECC1L variants, including a three-generation family, and a further individual of a previously published family. We discuss the nosology of Teebi and GBBB, and the syndromes related to SPECC1L variants. Although the phenotype of individuals with SPECC1L mutations shows overlap with Opitz syndrome in its craniofacial anomalies, the canonical laryngeal malformations and male genital anomalies are not observed. Instead, individuals with SPECCL1 variants have branchial fistulae, omphalocele, diaphragmatic hernias, and uterus didelphis. We also point to the clinical overlap of SPECC1L syndrome with mild Baraitser-Winter craniofrontofacial syndrome: they share similar dysmorphic features (wide, short nose with a large tip, cleft lip and palate, blepharoptosis, retrognathia, and craniosynostosis), although intellectual disability, neuronal migration defect, and muscular problems remain largely specific to Baraitser-Winter syndrome. In conclusion, we suggest that patients with pathogenic variants in SPECC1L should not be described as "dominant (or type 2) Opitz GBBB syndrome", and instead should be referred to as "SPECC1L syndrome" as both disorders show distinctive, non overlapping developmental anomalies beyond facial communalities.
Identifiants
pubmed: 30472488
pii: S1769-7212(18)30464-6
doi: 10.1016/j.ejmg.2018.11.022
pmc: PMC6594898
mid: NIHMS1028002
pii:
doi:
Substances chimiques
Phosphoproteins
0
SPECC1L protein, human
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103588Subventions
Organisme : NIDCR NIH HHS
ID : R01 DE026172
Pays : United States
Informations de copyright
Copyright © 2018. Published by Elsevier Masson SAS.
Références
Mol Genet Genomic Med. 2015 Dec 12;4(1):95-105
pubmed: 26788540
Hum Mutat. 2011 Aug;32(8):930-8
pubmed: 21542058
Am J Med Genet. 1991 Apr 1;39(1):78-80
pubmed: 1867268
Am J Med Genet. 1978;2(2):131-44
pubmed: 263433
Hum Mutat. 2008 May;29(5):584-94
pubmed: 18360914
J Med Genet. 2015 Feb;52(2):104-10
pubmed: 25412741
Am J Med Genet. 2002 Dec 1;113(3):302-6
pubmed: 12439902
Clin Genet. 1984 Aug;26(2):164
pubmed: 6467669
Clin Genet. 1983 Dec;24(6):446-8
pubmed: 6652958
Am J Med Genet. 1996 Mar 29;62(3):274-5
pubmed: 8882786
Front Biosci (Landmark Ed). 2016 Jan 01;21:664-82
pubmed: 26709798
Am J Med Genet A. 2015 Nov;167A(11):2497-502
pubmed: 26111080
Nat Genet. 1997 Nov;17(3):285-91
pubmed: 9354791
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Am J Med Genet A. 2006 Sep 15;140(18):1960-4
pubmed: 16906548
Hum Mutat. 2014 Jan;35(1):41-4
pubmed: 24115387
Am J Hum Genet. 2011 Jul 15;89(1):44-55
pubmed: 21703590
Clin Dysmorphol. 2003 Jul;12(3):187-9
pubmed: 14564158
J Med Genet. 1988 Mar;25(3):157-63
pubmed: 3351901
Am J Med Genet. 1996 Mar 29;62(3):305-17
pubmed: 8882794
Clin Dysmorphol. 1994 Oct;3(4):335-9
pubmed: 7894738
Am J Med Genet. 1998 Jun 5;77(5):345-7
pubmed: 9632162
Nat Genet. 1995 Dec;11(4):459-61
pubmed: 7493033
Sci Rep. 2016 Jan 20;6:17735
pubmed: 26787558
Am J Med Genet. 1987 Nov;28(3):581-91
pubmed: 3425628
Clin Dysmorphol. 2001 Apr;10(2):79-80
pubmed: 11311000
Mech Dev. 2012 Jan-Feb;128(11-12):560-76
pubmed: 22285438
Am J Med Genet. 1989 Nov;34(3):313-6
pubmed: 2688419
J Med Genet. 1988 Jun;25(6):427-9
pubmed: 3398011
J Med Genet. 1987 Nov;24(11):688-91
pubmed: 3430544
Eur J Hum Genet. 2015 Mar;23(3):292-301
pubmed: 25052316
Am J Med Genet. 1995 Oct 23;59(1):59-61
pubmed: 8849013
Hum Mutat. 2007 Feb;28(2):206-7
pubmed: 17221865
Am J Med Genet A. 2003 Mar 1;117A(2):181-3
pubmed: 12567419
Am J Med Genet A. 2007 Jun 15;143A(12):1282-6
pubmed: 17506099
Nat Genet. 2012 Feb 26;44(4):440-4, S1-2
pubmed: 22366783
Am J Med Genet. 1988 Nov;31(3):637-42
pubmed: 3228142